Brain Response to Reviewers: How to Write a Rebuttal That Holds Up (2026)

Brain is a clinical-neurology flagship, not a general neuroscience home. Its editors and associate editors are research-active translational neuroscientists, which sets the dual bar every referee applies: the paper must explain a neurological disease mechanism and carry genuine clinical relevance at the same time. That is why Brain rejects a large share of submissions before review at all for lack of novelty, studies of normal subjects, serious scientific flaws, or work outside scope.

Original articles that are predominantly methodological, or that present hypotheses and models unsupported by original data, are returned without peer review. Single case studies are not considered.

If your paper cleared that editorial triage and went to referees, you already passed the hardest screen. Brain sends suitable articles to at least two experts, whose reports go to the assigned associate editor and the Editor.

The referees are now testing whether the disease-mechanism claim survives scrutiny, with the clinical-decision impact of the work and methodological rigor weighing heavily, and their comments will concentrate on three places: the cohort or sample, the statistical analysis, and the strength of the mechanism-to-disease argument.

Brain's own instructions are unusually specific about statistics: a dedicated Statistical analysis section, the test statistic, degrees of freedom, the exact probability value, 95% confidence intervals encouraged, and a priori sample-size calculations with blinding and randomization detail. Treat any statistics comment as a request to meet that published standard, not as a stylistic preference.

The clinical-significance bar is the one authors underestimate. A reviewer who writes "the mechanistic finding is interesting but the clinical relevance is unclear" is not asking for a stronger Discussion paragraph. They are asking you to connect the mechanism to a measurable clinical feature, a patient phenotype, or a therapeutic implication, and to do it with data rather than assertion. Answering that comment with rhetoric is the response that draws a second major revision.

Source: Brain General Instructions, Oxford University Press (accessed June 2026), plus pre-submission review of Brain-targeted resubmissions.

The tone that works is collaborative, specific, and evidence-led. The tone that backfires is defensive, vague, or dismissive of the clinical-significance concern that defines the journal. Here are the contrasts that matter most for Brain.

Source: pre-submission review of Brain-targeted response letters, mapped to Brain General Instructions language.

Notice the pattern in the Better column: every reply names a manuscript component and a page or line. That is not decoration. It is the difference between a referee who can confirm your change in five seconds and a referee who has to take your word for it.

State a page and line reference for every change you claim to have made, and put the rule into practice from the first comment, not just when it is convenient. This is the most-cited rebuttal mistake in the literature and the one Brain referees flag most because Brain reads your responses in a paste field rather than a polished PDF.

Before you write the response letter, generate the revised manuscript with line numbering on and changes tracked, so the numbers you cite are stable. When you renumber after a later edit, re-check every reference. A response letter that points to "page 14" when the change moved to page 16 reads as careless to a referee who is already deciding whether your revision is thorough.

A second discipline that pays off at Brain specifically: put your substantive responses in the cut-and-paste field, not only in an attached letter. Brain warns that appended letters are not automatically sent to the referees, so a beautifully formatted PDF that lives only as an attachment may never reach the people deciding your fate. The Editor sees the cover letter; the referees see the paste field. Write for both.

In our pre-submission review work with Brain submissions, the same revision-stage failures repeat across manuscripts targeting this journal, and they are testable against your own paper before you resubmit. We see the same Brain editorial culture and triage pattern over and over, and Brain editors routinely flag the same gaps. These are the named failure patterns that most consistently turn a revisable Brain manuscript into a second major revision or a rejection.

The cohort that gets described instead of defended. Across our Brain pre-submission reviews, the most common referee-triggering weakness is a cohort or sample size that is reported but never justified. Brain referees, working from a journal that requires a priori sample-size calculations, read an unjustified cohort as a power problem.

The fix is not more participants; it is a power calculation in the Methods and an honest statement of what the cohort can and cannot detect. Check whether your sample size is justified or merely stated, because a referee will.

Clinical significance asserted in the Discussion, not demonstrated in the data. This is the Brain-specific trap. Manuscripts coming through pre-submission review for Brain frequently carry a strong mechanism and a Discussion paragraph that claims clinical relevance without an analysis behind it. Because Brain's editors are translational neuroscientists, that gap is the first thing referees probe. The manuscripts that survive revision add a figure or analysis linking the mechanism to a measurable clinical feature; the ones that stall keep arguing the point in prose.

Statistical reporting below Brain's published standard. Of the Brain-targeted manuscripts we pre-screen, a recurring referee comment is incomplete statistics: a P value with no test statistic, no degrees of freedom, no confidence interval, no sample-size rationale. Brain's General Instructions spell out exactly what the Statistical analysis section must contain, so this comment is fully predictable and fully avoidable. We flag any Results section that reports significance without the full apparatus Brain asks for.

The mechanism that is real but too basic for the clinical readership. Some Brain-targeted manuscripts are excellent neuroscience that never makes contact with neurological disease. When a referee writes "too basic for our readership," the honest read is often that the paper belongs at a mechanism-led venue or at Brain Communications, the open-access sister journal. We help authors decide before they burn a revision cycle defending a clinical angle the data cannot support.

Defensive responses to substantive comments. Across our Brain pre-submission reviews, the response-letter tone that predicts trouble is pushing back on cohort, statistics, or clinical-significance concerns without new evidence. These are the exact dimensions Brain referees are mandated to test, so contesting them with opinion rather than data reads as the author not understanding the journal. The strongest revisions concede early on substance and reserve pushback for clear factual misreadings, supported by pointing to the existing figure or analysis.

Each of these is checkable against your manuscript right now. Run a Brain cohort and clinical-significance check on the revised version before you paste your responses into Manuscript Central.

• Every referee comment is quoted, answered, and tied to a specific manuscript change with a page and line reference.
• The cohort or sample now carries an a priori power calculation, not just a description.
• The clinical-significance concern is answered with a new analysis or figure that links the mechanism to a measurable clinical feature, not with a rewritten Discussion paragraph.
• The Statistical analysis section reports the test statistic, degrees of freedom, exact P value, and confidence intervals that Brain's instructions ask for.
• Substantive responses are pasted into the response field, with only a short summary in the Editor cover letter.

A revision invitation at Brain is real progress, but it is not a promise. Brain states directly that revision gives no guarantee of acceptance, and that revised articles are rejected when the improvements are insufficient or when new issues arise during re-review. The numbers make the stakes concrete: after peer review, about 16% of submissions are recommended for revision or publication, and roughly 13% are ultimately recommended for publication. The gap between those two figures is the rejection-on-revision zone, and it is where a weak rebuttal does its damage.

The most common reasons a Brain revision fails on re-review: the cohort or statistical concern was acknowledged but not actually fixed, the clinical-significance gap was answered with prose instead of data, or a new flaw surfaced because the revision was rushed. There is also a tone failure mode: a response letter that argues with the referees on the journal's core dimensions reads as a misread of what Brain is, and that perception is hard to recover from in a second round.

If the science is sound but the priority or breadth fell short of Brain rather than the rigor, the Brain Communications transfer is the honest off-ramp. Brain Communications is the open-access sister journal, and the transfer carries your files and reviewer reports across so you do not resubmit from scratch.

Take it when reviewers liked the work but felt it was not quite a Brain-level clinical advance, and when you can fund the article processing charge, which runs around £2,906 for Brain Communications. Do not take it as a way to dodge a cohort or methods concern that will follow the paper wherever it goes. For how Brain handles a manuscript once it is under review, see the Brain under review guide.

Source: Brain General Instructions, Oxford University Press (accessed June 2026), plus pre-submission review of Brain-targeted resubmissions.

Across the response-to-reviewers craft literature, the durable guidance is the same one this guide applies to Brain: respond to every point, make the changes easy to find, and keep the tone collaborative even when you disagree.

The canonical reference is Ten Simple Rules for Writing a Response to Reviewers by William Stafford Noble in PLOS Computational Biology, and recent guidance in Nature Computational Science reinforces the same point-by-point discipline. Both pair well with Brain's own statistics and reporting standards. This guide was last reviewed against Brain's General Instructions on June 6, 2026.

Before you click resubmit, run a final Brain submission readiness check on the revised manuscript and the response letter together, or do a manual pass against the workflow above. The goal is simple: make the referee's job of confirming your changes faster than their job of doubting them.

• Manusights pre-submission review corpus, Brain-targeted manuscripts